chartexchange

LGNYZ
LIGAND PHARMS GENERAL CVR
stockOTCRight

EODNov 19, 2026
0.046USD+4.545%(+0.002)10,000
Loading…
Loading…
828,000
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
HQ
San Diego, CA, USA
Previous Close
$0.04
Beta
1.60
52-Week High
$0.09 2026-04-24
52-Week Low
$0.03 2026-07-02
SMA 50
$0.05
SMA 200
$0.04
Avg. Vol 10D
121,904
Avg. Vol 30D
560,754
Avg. Vol 90D
353,812
Relative Vol
0.02
19.55M
11,355
LGNYZ Profile

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.

LGNYZ Performance
PeriodPriceDateChangeBeta
1M0.052026-10-20-2.54%-3.395
3M0.052026-08-21-8.00%-0.568
6M0.072026-05-21-29.23%1.749
1Y0.042025-11-20+15.00%1.598
2Y0.012024-11-19+217.24%—
5Y0.012021-11-12+467.90%-1.382
LGNYZ Stock Summary

LIGAND PHARMS GENERAL CVR (OTC:LGNYZ) stock price today is $0.05, and today's volume is 10,000. LGNYZ is up 4.545% today. The 30 day average volume is 560,754. LGNYZ market cap is $828,000 with 18.00M shares outstanding.